Pacira BioSciences, Inc.
PCRX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $3.96M | $4.53M |
| Net Income | -$9.51M | -$7.90M |
| EPS Diluted | -$0.55 | -$13.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR